Skip to main content
RaySearch Laboratories logo

RaySearch Laboratories — Investor Relations & Filings

Ticker · RAY ISIN · SE0000135485 LEI · 549300TYFVYGS0JFWM28 ST Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 590 across all filing types
Latest filing 2017-11-02 Regulatory Filings
Country SE Sweden
Listing ST RAY

About RaySearch Laboratories

https://www.raysearchlabs.com/

RaySearch Laboratories develops advanced software solutions for radiation therapy and oncology. The company's product suite includes the RayStation® treatment planning system, the RayCare® oncology information system, and the RayIntelligence® oncology analytics system. These integrated platforms are engineered to enhance the efficiency, precision, and automation of cancer treatment workflows for clinics worldwide. By collaborating with leading cancer centers and research institutions, RaySearch aims to accelerate innovation in the field. The software is used by thousands of clinics to help clinicians plan and manage complex treatments, ultimately working to improve patient outcomes in the fight against cancer.

Recent filings

Filing Released Lang Actions
RayStation selected for CYCLHAD Hadrontherapy Center, France (Archade program)
Regulatory Filings Classification · 95% confidence The document is a press release announcing that RayStation has been selected as the treatment planning system for the CYCLHAD Hadrontherapy Center in France. It details the selection process, the technology involved, and includes quotes from the CEOs of both the customer (CYCLHAD) and the vendor (RaySearch). This type of announcement, which is not a formal regulatory filing (like 10-K, IR, or ER) but rather a business development update, fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate announcement, or potentially a 'Capital/Financing Update' (CAP) if it involved a major contract, but RNS is the most appropriate fallback for general news releases that don't fit specific categories like M&A or Director's Dealing. Given the content is a news announcement about a contract win, RNS is the best fit among the provided options for a non-standard filing.
2017-11-02 English
RaySearch releases preliminary outcome for the third quarter 2017
Earnings Release Classification · 99% confidence The document is titled "RAYSEARCH RELEASES PRELIMINARY OUTCOME FOR THE THIRD OUARTER 2017". It provides key preliminary financial figures (Net sales, operating profit, cash flow) for the third quarter of 2017 and explains the factors influencing these results. This content aligns perfectly with the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). It explicitly states that the full report will be released later, confirming this is the preliminary announcement, not the comprehensive report (like an IR or 10-K). Q3 2017
2017-11-01 English
RaySearch publicerar preliminärt resultat för tredje kvartalet 2017
Earnings Release Classification · 99% confidence The document is titled "PRESSMEDDELANDE" (Press Release) and announces the "PRELIMINARY RESULT FOR THE THIRD QUARTER 2017". It provides key financial highlights (Net Sales, Operating Result, Cash Flow) for the period and explains the factors affecting the results. Crucially, it states that the full report for January-September 2017 will be released on November 22, 2017. This structure—a brief announcement of preliminary key figures ahead of a full report release—is characteristic of an Earnings Release (ER). It is not the full report (IR or 10-K), nor is it a general announcement about publishing a report (RPA), as it contains the actual preliminary results. Q3 2017
2017-11-01 Swedish
RayStation achives strong precense in Japan market
Regulatory Filings Classification · 93% confidence The document is titled "PRESS RELEASE" and announces strong market presence and new orders for the RayStation treatment planning system in Japan during the third quarter of 2017. It discusses business developments, market penetration, and the establishment of a subsidiary. This type of announcement, focusing on operational achievements and market updates rather than formal financial statements (like 10-K or IR) or specific regulatory events (like DIRS or DIV), is best classified as a general business update or press release. Since there is no specific category for a general business press release that isn't an earnings release (ER) or a capital event (CAP), and it doesn't fit the definitions for AGM-R, AR, MANG, CT, DVA, DLST, DIRS, SR, XLSX, FS, CGR, IRAT, IR, IP, LTR, TAR, MRQ, MDA, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS, the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for miscellaneous regulatory announcements or press releases that don't fit elsewhere.
2017-10-24 English
RayStation har en stark närvaro på den japanska marknaden
Regulatory Filings Classification · 92% confidence The document is a press release dated October 24, 2017, detailing strong sales performance (13 new orders for RayStation in Q3 2017) and market presence in Japan. It discusses product updates (RayStation, upcoming RayCare) and company strategy, including the establishment of a subsidiary. This content is characteristic of an announcement regarding business performance and operational updates, which aligns best with an Earnings Release (ER) if it were quarterly results, or a general Regulatory Filing (RNS) if it doesn't fit a specific financial report type. Since it focuses on sales figures and market penetration rather than comprehensive financial statements (like 10-K or IR) or management changes (MANG), and it is a public announcement, RNS is the most appropriate general category, although it contains elements of an ER (quarterly order numbers). Given the lack of formal financial statements and the nature of a press release highlighting operational achievements, RNS serves as the best fit among the provided options, as it is not a formal financial report or a specific management/dividend announcement.
2017-10-24 Swedish
RaySearch färdigställer en betydande expansion av RayStation-plattformen vid Princess Margaret Cancer Center
Regulatory Filings Classification · 95% confidence The document is a press release dated September 21, 2017, announcing a significant expansion of RayStation platform licenses at Princess Margaret Cancer Center. It details a business transaction (a sale/contract win) involving the company's products and includes quotes from management and details about the involved entities. This type of announcement, detailing a specific business development or contract, does not fit neatly into the defined financial reporting categories (like 10-K, ER, IR) or specific corporate actions (like DIV, SHA, M&A). Since it is a general business update/news release that doesn't fit the other specific categories, the most appropriate fallback classification is Regulatory Filings (RNS), which serves as a general category for miscellaneous regulatory or significant company announcements not covered elsewhere.
2017-09-21 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.